tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market

Monte Rosa Therapeutics (GLUE) Technical Analysis

Compare
357 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Monte Rosa Therapeutics’s (GLUE) Moving Averages Convergence Divergence (MACD) indicator is 1.30, suggesting Monte Rosa Therapeutics is a Sell.
Monte Rosa Therapeutics’s (GLUE) 20-Day exponential moving average is 17.51, while Monte Rosa Therapeutics’s (GLUE) share price is $25.31, making it a Buy.
Monte Rosa Therapeutics’s (GLUE) 50-Day exponential moving average is 15.35, while Monte Rosa Therapeutics’s (GLUE) share price is $25.31, making it a Buy.

Monte Rosa Therapeutics (GLUE) Pivot Points

Jan 10, 2026, 11:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.17
19.14
21.21
23.18
25.25
27.22
29.29
Fibonacci
19.14
20.68
21.64
23.18
24.72
25.68
27.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Monte Rosa Therapeutics (GLUE) Moving Averages

Jan 10, 2026, 11:19 PM
Period
Simple
Exponential
MA5
18.86Buy
20.54Buy
MA10
17.70Buy
18.70Buy
MA20
17.15Buy
17.51Buy
MA50
15.55Buy
15.35Buy
MA100
11.28Buy
12.62Buy
MA200
7.99Buy
9.62Buy
Monte Rosa Therapeutics’s (GLUE) 10-Day exponential moving average is 18.70, while Monte Rosa Therapeutics’s (GLUE) share price is $25.31, making it a Buy.
Monte Rosa Therapeutics’s (GLUE) 100-Day exponential moving average is 12.62, while Monte Rosa Therapeutics’s (GLUE) share price is $25.31, making it a Buy.
Monte Rosa Therapeutics’s (GLUE) stock price is $25.31 and Monte Rosa Therapeutics’s (GLUE) 50-day simple moving average is 15.55, creating a Buy signal.
Monte Rosa Therapeutics’s (GLUE) stock price is $25.31 and Monte Rosa Therapeutics’s (GLUE) 100-day simple moving average is 11.28, creating a Buy signal.
Monte Rosa Therapeutics’s (GLUE) stock price is $25.31 and Monte Rosa Therapeutics’s (GLUE) 200-day simple moving average is 7.99, creating a Buy signal.

Monte Rosa Therapeutics (GLUE) Technical Indicators

Jan 10, 2026, 11:19 PM
Name
Value
Implied Action
RSI (14)
76.04
Sell
STOCH (9,6)
78.73
Neutral
STOCHRSI (14)
74.07
Neutral
MACD (12,26)
1.30
Sell
ADX (14)
28.80
Neutral
Williams %R
-3.81
Sell
CCI (14)
324.85
Sell
ATR (14)
1.90
-
Ultimate Oscillator
67.95
Neutral
ROC
51.10
Buy
Monte Rosa Therapeutics’s (GLUE) Relative Strength Index (RSI) is 76.04, creating a Sell signal.
Monte Rosa Therapeutics’s (GLUE) Trend Strength Indicator (ADX) is 28.80, creating a Neutral signal.
Monte Rosa Therapeutics’s (GLUE) Commodity Channel Index (CCI) is 324.85, creating a Sell signal.
Monte Rosa Therapeutics’s (GLUE) Price Rate of Change (ROC) is 51.10, creating a Buy signal.

FAQ

Is GLUE a Buy, Hold, or Sell?
Based on GLUE’s technical indicators, GLUE is a Buy.
    What is GLUE’s RSI (14)?
    GLUE’s RSI (14) is 76.04, which suggests GLUE is a Sell.
      What is GLUE’s MACD?
      GLUE’s MACD is 1.30, which suggests GLUE is a Sell.
        What is GLUE’s 5-day moving average?
        GLUE’s 5-day moving average is 18.86, which suggests GLUE is a Buy.
          What is GLUE’s 20-day moving average?
          GLUE 20-day moving average is 17.15, which suggests GLUE is a Buy.
            What is GLUE’s 50-day moving average?
            GLUE’s 50-day moving average is 15.55, which suggests GLUE is a Buy.
              What is GLUE’s 200-day moving average?
              GLUE’s 200-day moving average is 7.99, which suggests GLUE is a Buy.
                What is GLUE’s Williams % R (14)?
                GLUE’s Williams % R (14) is -3.81, which suggests GLUE is a Sell.
                  What is GLUE’s CCI (14)?
                  GLUE’s CCI (14) is 324.85, which suggests GLUE is a Sell.